EUVIMEDEUVIMED entdecken
Crossref

Triggered Cascade-Activation Nanoplatform to Alleviate Hypoxia for Effective Tumor Immunotherapy Guided by NIR-II Imaging

Yu Ji, Suchen Qu, Gaoyu Shi, Liansheng Fan, Jing Qian, Zhaorui Sun, Feng Lu iD, Xin Han iD

ACS Nano · 12.11.2024 · 18 (45) · 31421-31434

DOI: 10.1021/acsnano.4c11334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 04.11.2024. Verfasst von Yu Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Indu…. Hauptthemen laut MEDLINE: Immunotherapy, Hypoxia-Inducible Factor 1, alpha Subunit, Tumor Microenvironment, Tirapazamine. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyHypoxia-Inducible Factor 1, alpha SubunitTumor MicroenvironmentTirapazamineCRISPR-Cas SystemsHumansAnimalsMiceSilver CompoundsQuantum DotsInfrared RaysProdrugsSulfidesTumor HypoxiaCell Line, TumorSilicon DioxideNeoplasmsGene EditingAntineoplastic Agents

Stichwörter der Autor:innen

cascade-activationhypoxia-inducible factor-1immune-suppressive tumor microenvironmentprogrammed cell death ligand 1second near-infrared window imagingtirapazamine

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitTirapazamineSilver Compoundssilver sulfideProdrugsSulfidesSilicon DioxideAntineoplastic Agents

Autor:innen und Institutionen

  • The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medic…
  • Department of Emergency Medicine, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210002, China.
  • Key Laboratory for Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Teleco…

ORCID-Profile: Feng Lu, Xin Han

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Jiangsu Key Discipline Construction Fund of the 14th Five-Year Plan
  • Jiangsu Provincial Medical Youth Talent
  • Yangtze River Delta joint sci-tech innovation and research projects

Zitieren

APA

Ji, Y., Qu, S., Shi, G., Fan, L., Qian, J., Sun, Z., Lu, F., & Han, X. (2024). Triggered Cascade-Activation Nanoplatform to Alleviate Hypoxia for Effective Tumor Immunotherapy Guided by NIR-II Imaging. ACS Nano, 18(45), 31421-31434. https://doi.org/10.1021/acsnano.4c11334

Vancouver

Ji Y, Qu S, Shi G, Fan L, Qian J, Sun Z, et al. Triggered Cascade-Activation Nanoplatform to Alleviate Hypoxia for Effective Tumor Immunotherapy Guided by NIR-II Imaging. ACS Nano. 2024;18(45):31421-31434. doi:10.1021/acsnano.4c11334

BibTeX
@article{Ji2024,
  author = {Ji, Yu and Qu, Suchen and Shi, Gaoyu and Fan, Liansheng and Qian, Jing and Sun, Zhaorui and Lu, Feng and Han, Xin},
  title = {Triggered Cascade-Activation Nanoplatform to Alleviate Hypoxia for Effective Tumor Immunotherapy Guided by NIR-II Imaging},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {45},
  pages = {31421--31434},
  doi = {10.1021/acsnano.4c11334}
}
Kostenlos starten →